Follow the 제넥신 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 제넥신 has logged 38 reports. The latest transaction was disclosed on 10 March 2025 (Other). Among the most active insiders: 최재현. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
n/a
27 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Genexine is a biotechnology company focused on developing innovative therapeutics for autoimmune diseases and cancers. It is listed on the XKRX market.